Subject: New Research Report with Hefty Expectations Issued on Chinese Investors CIIX

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
New Research Report with Hefty Expectations Issued on Chinese Investors CIIX
Hot Stock to WatchHot Stock to Watch

Company: ChineseInvestors.com, Inc. (OTCQB: CIIX)


Last:

Price: 0.97

Change (%): - 0.06 (5.83)

Volume: 35,225
CIIX Chart

ChineseInvestors.com, Inc. (CIIX) Participates In SeeThruEquity Microcap Investor Conference, Receives Research Report Confidence in its Cannabis Market Penetration and Growth

ChineseInvestors.com, Inc. (OTCQB: CIIX) participated in SeeThruEquity’s 6th Annual Microcap Investor Conference on June 1, 2017, in New York. That conference gives investors the exclusive opportunity to discover publicly traded companies with market capitalization of less than 1 billion dollars.

CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California. There, it will sell primarily hemp oil-based products. The company is based in San Gabriel, California.

“SeeThruEquity gave CIIX a price target of $2.05 one year ago,” Warren Wang, founder and CEO of CIIX, noted in a news release. “Recently, the firm increased CIIX’s price target to $3.75, reflecting huge growth potential based on our legal medical cannabis initiatives. In addition, SeeThruEquity also gave CIIX a forecast for revenue from its hemp business projecting the revenue could grow from 0.7 million dollars in FY2017 to reach 8-digit sales by FY2020E, with continued growth thereafter.”

SeeThruEquity (http://nnw.fm/WRzu9) increased the price target on CIIX based on the potential for the company’s legal cannabis initiatives. These include CIIX’s early stage efforts to penetrate the market and the research company’s belief that CIIX can capitalize on its approach to broad cannabis industry growth.

“We view CIIX as a high-risk/high-reward investment opportunity in the microcap space, with potential of upside if the company can generate renewed traction with its high margin investor relations services business and execute on the new cannabis initiatives,” the report said.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks